Linking toll-like receptors signaling to oxidative damage: Potential role in cancer therapy

Abstract

Inflammation either promotes host defense or damages organs. Endogenous molecules generated upon oxidative damage can activate TLRs (toll-like receptors) that ultimately alert the innate immune system of danger. Although role of TLRs in the regulation of tissue injury is well established, however, their role in carcinogenesis is still obscure. In this chapter the main emphasis is to open new roads concerning the role of TLRs in devising new opportunities for drug development in cancer through manipulating immune responses.